Evolus, Inc. (EOLS)
6.42
+0.10
(+1.58%)
USD |
NASDAQ |
May 07, 09:44
Evolus Cash from Investing (Quarterly) : -1.691M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -1.239M |
| STAAR Surgical Co. | -19.42M |
| Quantum-Si, Inc. | 7.024M |
| Plus Therapeutics, Inc. | -1.077M |
| BioStem Technologies, Inc. | -0.4368M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.952M |
| Cash from Financing (Quarterly) | 7.619M |
| Free Cash Flow | -44.87M |
| Free Cash Flow Per Share (Quarterly) | -0.1786 |
| Free Cash Flow to Equity (Quarterly) | -21.55M |
| Free Cash Flow to Firm (Quarterly) | -7.570M |
| Free Cash Flow Yield | -10.76% |